Review
Version 1
Preserved in Portico This version is not peer-reviewed
Potential Drug Targets and Treatment Options for Covid-19: A Review
Version 1
: Received: 10 August 2022 / Approved: 11 August 2022 / Online: 11 August 2022 (08:07:05 CEST)
How to cite: Wubetu, M. Potential Drug Targets and Treatment Options for Covid-19: A Review. Preprints 2022, 2022080212. https://doi.org/10.20944/preprints202208.0212.v1 Wubetu, M. Potential Drug Targets and Treatment Options for Covid-19: A Review. Preprints 2022, 2022080212. https://doi.org/10.20944/preprints202208.0212.v1
Abstract
Background: A novel virulent coronavirus is what causes Novel Corona-virus Disease 2019 (nCOVID 19). It results in severe respiratory distress syndrome and potentially fatal infectious pneumonia. On March 12, 2020, the World Health Organization first labeled it a pandemic, which was then followed on the same day by a community health emergency of global concern. Vaccines against this deadly virus are now being created. Many drugs with different uses have been repurposed and tested for the prevention and treatment of the infection. Objective: The purpose of this review is to provide an in-depth analysis of data on possible pharmacological targets and available coronavirus treatments. Methods: Following the review protocol, a literature search was conducted. Results: Chloroquine phosphate and hydroxychloroquine, Remdesivir, and Lopinavir-Ritonavir in combination with or without interferon and convalescent plasma therapy are the main treatment candidates, according to the World Health Organization. This review article has elaborated on the current evidence of prospective pharmacological targets and related ongoing research, including inflammatory chemicals, bioactive peptides, beta cells, platelets, and the Angiotensin I Converting Enzyme 2 Receptor. This information was gathered from published journals. In addition, stories of medications and biological products like interferons and vaccinations that are utilized or could be utilized have been provided. Conclusion: There are a variety of pharmacological targets and therapeutic strategies that need more study.
Keywords
COVID-19; Drug targets; Inflammation; Treatment Options; Vaccines
Subject
Medicine and Pharmacology, Pharmacology and Toxicology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
